Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Quantitative Total Extensible Imaging (QTxI)

K-Number: K173444 · 2018-07-23

ApplicantAiq Solutions, Inc.
Decision Date2018-07-23
Product CodeLLZ
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

Quantitative Total Extensible Imaging (QTxI) is a medical device manufactured by Aiq Solutions, Inc.. It received FDA 510(k) clearance on 2018-07-23 under approval number K173444. The device is classified under product code LLZ. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Quantitative Total Extensible Imaging (QTxI)?

Quantitative Total Extensible Imaging (QTxI) is a medical device that received FDA 510(k) clearance on 2018-07-23. It is manufactured by Aiq Solutions, Inc.. The 510(k) number is K173444.

When was Quantitative Total Extensible Imaging (QTxI) approved by the FDA?

Quantitative Total Extensible Imaging (QTxI) received FDA 510(k) clearance on 2018-07-23, under approval number K173444.

What company makes Quantitative Total Extensible Imaging (QTxI)?

Quantitative Total Extensible Imaging (QTxI) is manufactured by Aiq Solutions, Inc..

What is the FDA product code for Quantitative Total Extensible Imaging (QTxI)?

The FDA product code for Quantitative Total Extensible Imaging (QTxI) is LLZ.

Related Clinical Trials

NCT07615972 Efficacy of a Roller Device Facilitating Self-massage in the Treatment of Chronic Lateral Epicondylitis NOT_YET_RECRUITING NCT03258580 Sociocultural & Biobehavioral Influences on Pain Expression and Assessment RECRUITING NCT07216274 Quantitative Transmission Imaging Compared With MRI as Supplemental Screening for High Lifetime Risk of Breast Cancer COMPLETED NCT06861309 Placental Imaging Techniques RECRUITING NCT03287596 Cartography and Quantitative Characterization of Achilles Tendon Fibrocartilage by TE = 0ms Imaging at 3T MRI COMPLETED NCT06795763 Acolyte CTO-PCI Study: Imaging and Catheter System to Treat Patients With Coronary Chronic Total Occlusion, Who Have Persistent Symptoms Following Medical Therapy and Are Undergoing Percutaneous Coronary Interventional Procedures ENROLLING_BY_INVITATION

Related Devices (Code: LLZ)

K161959ClearView cCADClearview Diagnostics, Inc. K163539Ez3D-i / E3Ewoosoft Co., Ltd. K162955Multi-Modality Tumor Tracking (MMTT) applicationPhilips Medical Systems Nederland B.V. K160852ZiaZetta Medical Technologies, LLC K162376CAAS MR 4D FlowPie Medical Imaging BV K161322CT CoPilotZepmed, LLC

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑